Literature DB >> 10101716

Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance.

J E Uzonna1, R S Kaushik, J R Gordon, H Tabel.   

Abstract

We studied IL-4, IL-10 and IFN-gamma secretion by splenocytes and the plasma levels of different isotypes of antibodies against various antigens of Trypanosoma congolense in highly susceptible BALB/c and relatively resistant C57BL/6 mice during the early course of infection with T. congolense. The patterns of appearance of cytokine spotforming cells in the spleens were essentially similar in the two mouse strains although higher numbers were detected in the spleens of BALB/c than C57BL/6 mice on some days post-infection. However, the amount of IL-4, IL-10 and IFN-gamma secreted into the culture fluids was dramatically different. From day 4 forward, splenocytes from BALB/c mice secreted very high levels of these cytokines. In contrast, splenocytes from infected C57BL/6 mice did not secrete detectable levels of IL-4 throughout the period tested. The secretion of IL-10 and IFN-gamma by C57BL/6 splenocytes only became appreciable on day 6 and was down-regulated by day 8, when the first wave of parasitaemia was being controlled. At days 6-8, splenocytes from infected C57BL/6 mice secreted two-fold higher amounts of IL-12 p40 than those from BALB/c mice. Infected BALB/c mice mounted an earlier IgM antibody response to variant surface glycoprotein (VSG), formalin-fixed T. congolense and whole T. congolense lysates than did infected C57BL/6 mice. However, they failed to make any detectable IgG3 and IgG2a antibody responses to these antigens whereas infected C57BL/6 mice made strong IgG3 and IgG2a responses. We speculate that enhanced resistance against T. congolense infections in mice may be mediated by IL-12 dependent synthesis of IgG2 antibodies to VSG and possibly also common trypanosomal antigens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101716     DOI: 10.1046/j.1365-3024.1999.00202.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  24 in total

1.  Immunobiology of African trypanosomes: need of alternative interventions.

Authors:  Toya Nath Baral
Journal:  J Biomed Biotechnol       Date:  2010-02-23

2.  Gene expression profiling in a mouse model for African trypanosomiasis.

Authors:  S Kierstein; H Noyes; J Naessens; Y Nakamura; C Pritchard; J Gibson; S Kemp; A Brass
Journal:  Genes Immun       Date:  2006-10-26       Impact factor: 2.676

3.  Diminazene aceturate (Berenil) downregulates Trypanosoma congolense-induced proinflammatory cytokine production by altering phosphorylation of MAPK and STAT proteins.

Authors:  Shiby M Kuriakose; Chukwunonso Onyilagha; Rani Singh; Ping Jia; Jude E Uzonna
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

4.  Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice.

Authors:  Wim Noël; Gholamreza Hassanzadeh; Geert Raes; Boniface Namangala; Inge Daems; Lea Brys; Frank Brombacher; Patrick De Baetselier; Alain Beschin
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Interleukin-17-mediated control of parasitemia in experimental Trypanosoma congolense infection in mice.

Authors:  Zhirong Mou; Ping Jia; Shiby Kuriakose; Forough Khadem; Jude E Uzonna
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

6.  Effects of exogenous transforming growth factor beta on Trypanosoma congolense infection in mice.

Authors:  Boniface Namangala; Chihiro Sugimoto; Noboru Inoue
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

7.  Distinct Contributions of CD4+ and CD8+ T Cells to Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma Interferon and Interleukin-10.

Authors:  Gongguan Liu; Donglei Sun; Hui Wu; Mingshun Zhang; Haixia Huan; Jinjun Xu; Xiquan Zhang; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

8.  Immunolocalization and challenge studies using a recombinant Vibrio cholerae ghost expressing Trypanosoma brucei Ca(2+) ATPase (TBCA2) antigen.

Authors:  Kiantra Ramey; Francis O Eko; Winston E Thompson; Henry Armah; Joseph U Igietseme; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2009-09       Impact factor: 2.345

9.  Low-dose intradermal infection with trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection.

Authors:  Chukwunonso Onyilagha; Ifeoma Okwor; Shiby Kuriakose; Rani Singh; Jude Uzonna
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

10.  Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis.

Authors:  Taylor R Dagenais; Bailey E Freeman; Karen P Demick; Donna M Paulnock; John M Mansfield
Journal:  J Immunol       Date:  2009-08-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.